We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Instem Plc | LSE:INS | London | Ordinary Share | GB00B3TQCK30 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 830.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMINS
RNS Number : 8537F
Instem plc
26 February 2018
Instem plc
("Instem" or the "Company")
Grants to Directors under the Instem Long Term Incentive Plan ('LTIP')
Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that Chief Executive Officer, Phil Reason and Chief Financial Officer, Nigel Goldsmith have each been granted nil-cost options over 80,000 Instem ordinary shares of 10p ("Ordinary Shares") under the Company's long-term incentive plan ("LTIP").
These 160,000 share options will become exercisable in 2021, subject to meeting share price targets, pursuant to the rules of the LTIP, which was approved by the Board on 22 February 2018. Following exercise of the options, the resulting shares will then be subject to a minimum 12-month holding period.
After these grants of options, Phil Reason and Nigel Goldsmith hold a total of 384,606 and 217,500 share options, respectively whilst their holdings in Ordinary Shares remain unchanged at 665,287 and Nil, respectively.
For further information, please contact:
Instem plc +44 (0) 1785 825 600 Phil Reason, CEO Nigel Goldsmith, CFO N+1 Singer (Nominated Adviser & Broker) +44 (0) 20 7496 3000 Richard Lindley James White Rachel Hayes Walbrook Financial PR +44 (0) 20 7933 8000 Paul Cornelius instem@walbrookpr.com Helen Cresswell Sam Allen
About Instem
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please visit instem.com.
1 Details of the person discharging managerial responsibilities / person closely associated --- ---------------------------------------------------------- a) Name Phil Reason --- ------------------------- ------------------------------- 2 Reason for the notification --- ---------------------------------------------------------- a) Position/status Chief Executive Officer --- ------------------------- ------------------------------- b) Initial notification Initial notification /Amendment --- ------------------------- ------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ---------------------------------------------------------- a) Name Instem plc --- ------------------------- ------------------------------- b) LEI 213800PILYUFNNROQX68 --- ------------------------- ------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------------- a) Description of Options over Ordinary Shares the financial of 10p each instrument, type of instrument ISIN Code: GB00B3TQCK30 Identification code --- ------------------------- ------------------------------- b) Nature of the (i) Grant of options over transaction Ordinary Shares --- ------------------------- ------------------------------- c) Price(s) and volume(s) Price(s): Volume(s): (i) Nil 80,000 --- ------------------------- ------------------------------- d) Aggregated information N/A - Aggregated volume - Price --- ------------------------- ------------------------------- e) Date of the transaction 22/02/2018 --- ------------------------- ------------------------------- f) Place of the transaction Off market --- ------------------------- ------------------------------- 1 Details of the person discharging managerial responsibilities / person closely associated --- ----------------------------------------------------------- a) Name Nigel Goldsmith --- ------------------------- -------------------------------- 2 Reason for the notification --- ----------------------------------------------------------- a) Position/status Chief Financial Officer --- ------------------------- -------------------------------- b) Initial notification Initial notification /Amendment --- ------------------------- -------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------- a) Name Instem plc --- ------------------------- -------------------------------- b) LEI 213800PILYUFNNROQX68 --- ------------------------- -------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------- a) Description of Options over Ordinary Shares the financial of 10p each instrument, type of instrument ISIN Code: GB00B3TQCK30 Identification code --- ------------------------- -------------------------------- b) Nature of the (ii) Grant of options over transaction Ordinary Shares --- ------------------------- -------------------------------- c) Price(s) and volume(s) Price(s): Volume(s): (ii) Nil 80,000 --- ------------------------- -------------------------------- d) Aggregated information N/A - Aggregated volume - Price --- ------------------------- -------------------------------- e) Date of the transaction 22/02/2018 --- ------------------------- -------------------------------- f) Place of the transaction Off market --- ------------------------- --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHUVRARWNAUUAR
(END) Dow Jones Newswires
February 26, 2018 02:01 ET (07:01 GMT)
1 Year Instem Chart |
1 Month Instem Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions